Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT03569033
Eligibility Criteria:
Inclusion Criteria:
* In good general health
* Susceptible to human rhinovirus type 16 (HRV-16)
* Male or non-pregnant and non-breast feeding female
* If female of reproductive potential, agrees to use 1 form of acceptable birth control
Exclusion Criteria:
* Donated blood within 56 days or donated plasma within 7 days prior to dosing
* History of significant multiple and/or severe allergies
* Recent history of respiratory tract infection
* History of cancer
* Body mass index \<18 kg/m\^2 or ≥40 kg/m\^2
* History of major surgery or loss of 1 unit of blood
* History of allergic reaction to sulfonamides
* Received medications within 14 days prior to randomization
* Significantly abnormal laboratory tests at Screening
* Current smoker, smoked within 5 years of Screening, or significant past smoking history
* History of alcohol or drug abuse
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03569033
Study Brief:
Protocol Section:
NCT03569033